Takayasu's arteritis: a cell-mediated large-vessel vasculitis

Area of Science:

• Vascular Inflammation
• Autoimmune Diseases
• Rheumatology

Background:

• Takayasu's arteritis is an idiopathic, systemic inflammatory condition targeting the aorta and its major arteries.
• Pathogenesis involves cell-mediated autoimmunity, leading to granulomatous inflammation, fibrosis, and potential stenosis or aneurysms.
• Clinical manifestations are diverse, ranging from asymptomatic cases to severe systemic and organ-specific symptoms.

Purpose of the Study:

• To provide a comprehensive overview of Takayasu's arteritis.
• To highlight diagnostic criteria and challenges in assessing disease activity.
• To discuss current therapeutic strategies.

Main Methods:

• Literature review of Takayasu's arteritis pathogenesis, clinical presentation, diagnosis, and management.
• Analysis of diagnostic imaging findings (e.g., stenosis, aneurysms).
• Review of treatment modalities including corticosteroids, cytotoxic agents, surgery, and interventional radiology.

Main Results:

• Takayasu's arteritis presents heterogeneously with potential vascular, neurological, cardiac, and pulmonary complications.
• Diagnosis relies on clinical features and vascular imaging, but assessing active inflammation remains challenging.
• Effective treatments include high-dose corticosteroids, often combined with cytotoxic agents for active disease.

Conclusions:

• Takayasu's arteritis requires a multidisciplinary approach for diagnosis and management.
• Early intervention is key to preventing irreversible vascular damage and end-organ complications.
• Ongoing research is needed to improve disease activity assessment and treatment efficacy.